SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors

NCT00004049 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: apomine

Sponsor

Genzyme, a Sanofi Company